An Investigational Drug Branch (IDB) is an organizational or regulatory unit that supports oversight of investigational drug development activities.
Depending on the setting, an IDB may coordinate protocol review, safety monitoring expectations, product accountability requirements, and regulatory documentation workflows. In clinical trials, IDB involvement helps align investigational product handling and oversight practices across studies and sites. Clear governance supports consistent escalation pathways for safety issues, deviations, and compliance concerns. IDB processes help strengthen quality control and support inspection readiness across a development program.